Endonovo Therapeutics
Woodland Hills, US · Founded 2011
Founders & leadership
MM
Michael MannExecutive Officer
AC
Alan CollierExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$225KraisedNov 2019 · 4 investors · Biotechnology
Rule 506(c)$700KraisedDec 2017 · 13 investors · Biotechnology
Rule 506(c)$211.3KraisedFeb 2016 · 6 investors · Other
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.